UnitedHealth Group Inc (UNH) : Argentus Capital Management reduced its stake in UnitedHealth Group Inc by 3.95% during the most recent quarter end. The investment management company now holds a total of 15,753 shares of UnitedHealth Group Inc which is valued at $2 Million after selling 648 shares in UnitedHealth Group Inc , the firm said in a disclosure report filed with the SEC on May 13, 2016.UnitedHealth Group Inc makes up approximately 0.73% of Argentus Capital Management’s portfolio.
Other Hedge Funds, Including , Brown Advisory Inc reduced its stake in UNH by selling 5,751 shares or 1.38% in the most recent quarter. The Hedge Fund company now holds 410,770 shares of UNH which is valued at $53 Million. UnitedHealth Group Inc makes up approx 0.18% of Brown Advisory Inc’s portfolio.Accredited Investors boosted its stake in UNH in the latest quarter, The investment management firm added 100 additional shares and now holds a total of 2,317 shares of UnitedHealth Group Inc which is valued at $298,893. UnitedHealth Group Inc makes up approx 0.08% of Accredited Investors’s portfolio.Tiaa Cref Investment Management boosted its stake in UNH in the latest quarter, The investment management firm added 415,435 additional shares and now holds a total of 5,440,548 shares of UnitedHealth Group Inc which is valued at $718.4 Million. UnitedHealth Group Inc makes up approx 0.54% of Tiaa Cref Investment Management’s portfolio.Parkwood reduced its stake in UNH by selling 2,793 shares or 52.61% in the most recent quarter. The Hedge Fund company now holds 2,516 shares of UNH which is valued at $332,213. UnitedHealth Group Inc makes up approx 0.06% of Parkwood’s portfolio.
UnitedHealth Group Inc opened for trading at $133.21 and hit $134.3 on the upside on Wednesday, eventually ending the session at $133.42, with a gain of 0.63% or 0.83 points. The heightened volatility saw the trading volume jump to 22,11,337 shares. Company has a market cap of $126,856 M.
On the company’s financial health, UnitedHealth Group Inc reported $1.81 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Apr 19, 2016. Analyst had a consensus of $1.72. The company had revenue of $44527.00 million for the quarter, compared to analysts expectations of $44278.96 million. The company’s revenue was up 24.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.
Many Wall Street Analysts have commented on UnitedHealth Group Inc. Company shares were Reiterated by Mizuho on Apr 20, 2016 to “Buy”, Firm has raised the Price Target to $ 156 from a previous price target of $150 .Company shares were Reiterated by FBR Capital on Apr 19, 2016 to “Outperform”, Firm has raised the Price Target to $ 145 from a previous price target of $130 .Company shares were Reiterated by Mizuho on Mar 15, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $131 .
UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.